Skip to main content

Patterns and sociodemographic characteristics of substance abuse among hepatitis C virus-infected patients in Iraq: a cross-sectional study

Abstract

Background

Substance use disorders are a widely recognized problem among hepatitis C-infected patients; moreover, substance abuse by intravenous injection is a common mode of transmission of the hepatitis C virus worldwide. The frequency of substance use disorders and their relation to hepatitis C infection are still unknown in Iraq. This cross-sectional study, conducted among a sample of hepatitis C- infected patients attending the Gastrointestinal Tract Center in Baghdad Medical City, aimed to examine the prevalence of substance use disorders, the sociodemographic characteristics of the abusers, and the relation between intravenous drug abuse and hepatitis C virus infection. All participants were subjected to an Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) questionnaire and a data form to determine sociodemographic characteristics and hepatitis C virus-related risk factors.

Results

In a total of 300 hepatitis C virus-infected patients, the prevalence of substance use disorders was 53.6%. Among these patients, 43.6% abused nicotine, 6% abused licit drugs, and 4% abused alcohol. No one reported illicit drug abuse. Intravenous drug abuse was rare, and there was no relationship found between intravenous drug abuse and hepatitis C infection. Cupping (23%) and blood transfusion (20.3%) were both significantly associated with hepatitis C transmission in this study (p > 0.001).

Conclusion

This study revealed a high prevalence (53.6%) of substance abuse in this sample of hepatitis C-infected patients, with nicotine being the most commonly abused substance. However, there was no relationship between hepatitis C infection and intravenous drug abuse. Common risk factors that might contribute to hepatitis C transmission among this population include cupping and blood transfusion.

Background

Substance use disorder (SUD) is a complex condition involving patterns of symptoms caused by the uncontrolled use of a substance despite its harmful consequences [1]. Substance abuse is a serious public health problem throughout the world [2]. The World Health Organization (WHO) reported that approximately 1 billion people smoke tobacco worldwide, despite the fact that tobacco is the main cause of morbidity and mortality [3]. Alcohol abuse is also a serious and prevalent mental disorder; however, WHO data reveal that 76.5 million people struggle with alcohol-related disorders [4]. Furthermore, nearly 5% of people aged 15–64 consume illicit drugs worldwide [5]. Cannabis and Amphetamine-type stimulants (ATS) are the two most frequently abused illicit drugs, with a global annual prevalence of 2.6–5% and 0.3–1.2%, respectively [6]. Licit drugs (prescription medications), such as sedatives, analgesics, hypnotics, and opioid substitution drugs, are largely misused to produce psychoactive effects. The United Nations International Narcotics Control Board expects that misuse of licit drugs will overcome illicit drug abuse globally [7]. It has been shown that women and individuals from lower social classes are more prone to misuse prescription drugs [8, 9]. In the United States (US), prescription medicines are the second most abused drugs after cannabis [10].

In Iraq, a few epidemiological studies on SUD were conducted before 2003, which may align with the fact that Iraq had the lowest rates of substance abuse, according to WHO reports from 2002 [11]. After 2003, there was considerable evidence of an increase in drug abuse and long-term mental health conditions like depression [12, 13]. The substances commonly abused in Iraq are alcohol and prescription medicines, such as tramadol, benzodiazepines, codeine, and benzhexol, and there has been an increase in the abuse of hashish and ATS in some regions. Substance abuse is predominant among young males, and licit drug abuse is the most common type, as there are few restrictions on these drugs, which can be obtained without prescription [14].The Iraqi National Household Survey on Alcohol and Drug Use (INHSAD) revealed that lifetime tobacco use was reported by 28.8%, lifetime alcohol use by 8.1%, licit drug use by 2.9%, and illicit drug use by 0.3% [15], while the Iraqi Mental Health Survey found lifetime alcohol abuse to reach a rate of 6.8% among men and 0.6% among women, and the lifetime prevalence of licit drug misuse was 7% [16]. Before 2009, Iraqi authorities frequently seized cannabis, with opium accounting for 15% of all drugs in 2010; however, this rate dropped to 5% in 2011 [14].

Hepatitis C virus (HCV) infection is increasingly recognized as a significant healthcare problem worldwide, with more than 170 million people suffering from this chronic infection [17]. HCV is highly prevalent among injection drug users (IDUs) [18]. IDUs acquire infection by coming into contact with blood during the act of injecting, as a result of sharing needles, syringes, and other injection equipment [19]. In Iraq, there is a low endemicity of both the hepatitis B virus and HCV, with prevalence rates of 1.6% and 0.4%, respectively [20]. In contrast, HCV prevalence among IDUs in Saudi Arabia ranged from 14.4% to 74% [21]. In the U.S., 75–90% of long-term IDU showed hepatitis C seroprevalence [22]. As the above numbers demonstrate, intravenous drug abuse is the main risk factor for HCV transmission [23]. In light of these findings, our study was conducted to identify the prevalence of substance use disorders among HCV-infected patients, their sociodemographic characteristics, and the relationship between intravenous drug abuse and HCV infection.

Methods

Study design and participants

This cross-sectional study was conducted at the Gastrointestinal Tract Center, Baghdad Medical City, Baghdad, Iraq. The participants were hepatitis C-infected patients who attended the outpatient clinic of the Center to receive treatment and follow-up. The total patients were 1600; 310 patients were involved in the study according to an online sample size calculator with the following equation:

$${\text{n}}\, = \,[{\text{DEFF}}*{\text{Np}}\left( {{1} - {\text{p}}} \right)\left] {/ \, } \right[({\text{d}}^{{2}} /{\text{Z}}.^{{\mathbf{2}}}_{{{\mathbf{1}} - {{\varvec{\upalpha}}}/{\mathbf{2}}}} *\left( {{\mathbf{N}} - {\mathbf{1}}} \right)\, + \,{\mathbf{p}}*\left( {{\mathbf{1}} - {\mathbf{p}}} \right)].$$

Population size (N) = 1600

Hypothesized % frequency of outcome factor in the population (p): 50% ± 5

Confidence limits (d) = 5%

Design effect (DEFF) = 1

Z score = 1.96

Sample size = n.

Ten patients did not complete the interview, so the number of respondents was reduced to 300. The data were collected once a week from May 2017 to October 2017 and purposive sampling method was used. We included both genders who were medically stable and over 18. Those who were severely ill and declined to participate were excluded.

Data collection

All patients were subjected to the following:

1. Patients had to complete a form to determine their sociodemographic characteristics and HCV-related risk factors (age, gender, residence, occupation, education and marital status, and crowding index, which was determined by dividing the number of people living in the house by the number of rooms). The assessed risk factors related to HCV transmission include injection drug use, tattoos, surgery, dialysis, dental procedures, cupping, and blood transfusions.

2. Patients had to complete the WHO ASSIST (Arabic version) to screen for psychoactive substance use.

The Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) is a brief screening tool used in primary care and other settings to determine whether people use psychoactive substances. It was developed by the WHO and validated in Arabic as a simple method of screening for hazardous, harmful, and dependent use of substances [24, 25]. There are eight questions on the ASSIST (the first seven inquire about the usage and problems associated with alcohol, tobacco, cocaine, cannabis, ATS, inhalants, sedatives, opioids, and hallucinogens; the eighth concentrates on injecting and inquires whether the patient has ever injected any drug). Accordingly, ASSIST provides information about:

  • ✓ Substance people have ever used in their lifetime.

  • ✓ Substances they have used over the last three months.

  • ✓ Dependence.

  • ✓ Injection drug use.

Specific substance involvement scores for all substances except alcohol are scored as follows: 0–3 indicates low risk, 11–26 indicates moderate risk, and 27 + indicates high risk. For alcohol, 0–10 indicates low risk, 11–26 indicates moderate risk, and 27 + is associated with high risk. A low risk score means that there is a lower risk associated with the use of the involved substance, moderate risk score means harmful or hazardous use of that substance, and high-risk score means there is a high risk of substance dependence.

Statistical analysis

IBM© SPSS© (Statistical Package for the Social Sciences) Version 22 and Epi Info™ 7 were used for data tabulation, input, and coding. For descriptive analysis, frequencies were applied in various categories. The Chi-square test (95% confidence interval) was used to investigate the associations between variables; a p value of less than 0.05 was considered significant, while a p value less than 0.001 was considered highly significant.

Ethical approval

The aims of the study were explained to the patients before data collection, and all patients signed an informed consent form to participate in the study. All the data used in this study were kept confidential. The study was approved by the scientific council of psychiatry of the Arab Board for Health Specializations (No. 183, February 5th, 2017).

Results

Descriptive characteristics of the sample

The researcher approached 310 HCV-infected patients, of whom 300 adults responded (response rate: 96.7%). The mean age of the respondents was 39.1 ± 13.2 years; more than half were male (53.6%), married (69.7%), and employed (60.3%). Most lived in urban areas (67.3%); 40.3% had only a primary education. The prevalence of substance abuse was 53.6% (n = 161) in this sample, with 43.6% abusing nicotine, 6% licit drugs, and 4% alcohol. No one reported illicit drug abuse, as shown in Table 1. A total of 161 patients were substance abusers, who were then divided into three groups according to the abused substance, as shown in Table 2.

Table 1 Socio-demographic characteristics of HCV-infected patients (n = 300)
Table 2 Socio-demographic characteristics of the substance abuse groups (n = 161)

Tobacco abuse group

A total of 43.6% reported tobacco abuse; the mean age was 39.4 years (SD 4.2); the highest age group was 48 + with 39 patients (13%), 100 patients (33.3%) were of male gender, 89 patients (67.9%) were living in urban areas, 102 patients (77.8%) were employed, 87 patients (66.4%) were married, and 52 patients (39.7%) received primary education in an area with a high household crowding index (HCI) 2.03.

Alcohol abuse group

Of the participants, 4% reported alcohol abuse; the mean age was 43 years (SD 8.99); the highest age group was 38–47 years with nine patients (3%), exclusively male gender; 12 (100%) of the patients lived in urban areas. Most of them were employed (75%), and less than half had received primary and secondary education (0.33%). Six patients (50%) were married and a high mean HCI (1.4) was revealed.

Licit drug misuse group.

Of all patients, 6% reported licit drug abuse, with this use being distributed as follows: diazepam tablets by 4.3%, tramadol tablets by 0.7%, and alprazolam tablets by 1%, as shown in Fig. 1. Their mean age was 39.5 years (SD 11.55), and the highest age group was 28–37 with seven patients (2.3%); 14 (4.66%) were females, the majority lived in urban areas and were married 16 (88.9%), 11 patients (61.1%) were unemployed, and seven patients (38.9%) received primary education in an area with a high HCI of 1.7.

Fig. 1
figure 1

Types of abused substances

Illicit drug abuse group

No one reported abusing such drugs.

A univariate analysis showed a significant association between substance abuse and gender, residence (urban), employment, and a high mean HCI. No significant differences were observed between substance abuse and other variables (education and marital status), as shown in Table 2. In terms of the route of administration, smoking was the most common route for 131 patients (43.6%), as shown in Fig. 2. Regarding the risk factors identified in the study, the most relevant risk factor for HCV transmission was cupping which had been reported by 69 patients (23%), as shown in Fig. 3.

Fig. 2
figure 2

Risk factors related to hepatitis C infection

Fig. 3
figure 3

Route of consuming the substances

Discussion

To our knowledge, no data are available on substance use disorders among HCV-infected patients in Iraq. Nevertheless, worldwide studies show higher infection rates among drug abusers compared to the general population, especially among those who inject drugs.

Socio-demographic characteristics

The mean age of our study sample was 39.1 + 13.2 years which aligns with a study conducted in France [26], with 53.6% of male gender similar to Garfein et al., while 69.7% were married contrary to Garfein et al. [27] in which majority were never married due to Islam encourage marriage, 52.3% employed, 40.3% received primary education, and 67.3% of urban background.

Tobacco abuse group

The INHSAD revealed current tobacco use 23.4%, largely in males; highest age group is 18–34 years by 33.1%, most of them were employed 41.2%, were widowed or divorced 32.4% of the contrary to our study (married 66.4%), 36.8% achieve primary education, and HCI is 2.5 [15]. Other two studies in Iraq including the Iraqi Family Health Survey and the Iraqi Ministry of Health Non-communicable Disease Risk Factor Survey reported tobacco use to be 14.8% and 21.9%, respectively [28, 29]. Whereas Butt's study in the United States revealed 6.1% abuse tobacco which is lower than our study, their mean age was 57 years, predominantly of male gender 57.6% [30].

The reasons for these differences may be due to different study design characteristics, such as sample size, measurement tools, and study methods, while Hezode study found most participants (40%) were tobacco abusers similar to our study [26].

Alcohol abuse group

In The INHSAD survey, current alcohol abuse was 3.4% nearly the same as our study (4%), males have a higher value than women, urban higher than rural, married, and finally, primary education are consistent with our study [15]. A similar result was found in an Indian study in which alcohol abuse was exclusively male and participants achieved primary education [31]. In the Al-Hemiary study in Iraq, the lifetime prevalence of alcohol abuse was 16.7%; exclusively in males, the peak age was 24–35 years, and the majority were illiterate (73%), with a high HCI [32]. In contrast, the Hezode study, Butt study, and Fireman study, the alcohol abuse rate was 13.3%, 14%, and 21% respectively, all higher than our study but similar in being exclusively in males [26, 30, 33]. This high rate is due to the Islamic prohibition of alcohol, and all participants were obliged to avoid alcohol because of their liver disease.

Licit drug misuse

In our study, women were more likely than men to abuse prescription drugs. The most common drugs reported to be abused were painkillers (tramadol) and antianxiety drugs (diazepam and alprazolam); the female-specific conditions of dysmenorrhea and the high rate of anxiety disorders in women could partly explain these findings [35]. Another explanation is the different healthcare system approach between men and women [34]. These findings are consistent with those reported in a Swedish study [9]. The INHSAD showed that 1.2% of respondents used licit drugs, which was lower than in our study 6%, with a higher male preponderance which differs from our study. The highest age group (18–34 years) similar to our study, as was the finding that most were unemployed, significant number were widowed or divorced, which is contrary to our study showing that most were married [15]. In contrast, Alhasnawi found a lifetime prevalence 0.7% which is very low compared to most studies conducted in Iraq, including our study; however, higher numbers of men and widowed or divorced could be explained by this study having been completed during the year of violence 2006 and the exclusion of residents of dangerous areas[16]. In this sense, it should be noted that Al-Hemiary’s study revealed lifetime prevalence of 7%, and a peak age of 24–35 years, along with male exclusivity. This is contrary to our study, in which female use was predominant. Likewise, 15% were illiterate, and primary education numbers were similar to those of our study [32].

Illicit drug abuse

In our study, no one use such drugs, while in the INHSAD, current use was 0.2% (cannabis, inhalants, Captagon, opium) [15], the Hezodes' study revealed that 24.1% were daily cannabis users, and 7.3% were on methadone and buprenorphine, as these are commonly abused drugs in Europe [26].Similarly, studies in Iran have found a high prevalence of illicit drug abuse, as in Amiri's study, where illicit drug use was divided among opium (51.7%), heroin (18.3%), cannabis (12.4%), and others (17.6%). In this case, respondents had a mean age of 34.7 years, all of whom were of the male gender; 63.4% were married, 50% were illiterate or had a primary education, and 90% were smokers, which is in consonance with our study [36]. In Norouzian's study in Iran, the abused substances were heroin (17.9%), opium (7.1%), and methamphetamine (5.4%); most were male, 67% were employed, ages ranged from 19 to 51 years, 60% had less than a high school education, and 93% were single; this could be explained by the fact that in Iran, illicit drug abuse, especially opiates and cannabis, is highly prevalent [37]. Studies in Arabic countries, such as Saudi Arabia found that the majority of those abusing illicit drugs and alcohol were male, single, and had achieved a secondary education [48]. Also, studies in Kuwait and Syria showed that the majority of IDUs were males [49, 50].

Route of consuming the substance

In our study, the most common route of consuming the substance was smoking, followed by oral use, and only one participant reported an intravenous route. Nourozian's study In Iran found that injection and inhalation were prevalent [37], which is contrary to our study, as in Iran the most commonly abused drugs are opiates, while in Iraq, the most frequently abused substances are prescription drugs, alcohol and nicotine. Likewise, Amiri's study in Iran showed inhalation and oral route rates similar to those of our study [36].

Risk factors for hepatitis C

In our study, cupping and blood transfusion were the most common risk factors for hepatitis C infection, as in Iraqi society, cupping therapy is commonly practiced using unsterilized equipment. Also, transfusion of blood and blood products is still a major mode of HCV transmission in Arab countries, including Iraq, due to the lack of organized infrastructure and well-trained staff to meet the standards of modern blood transfusion systems [38]. In Iraq, studies by Khattab and Al-Kubaisy found blood transfusion to be the most common factor related to HCV acquisition [39, 40]. Similarly, a study conducted both Saudi Arabia and Iran revealed blood transfusion to be a common factor, as in our study [41, 42], where as another study in Saudi Arabia showed that intravenous drug use was most common due to the prevalence of opiates abuse in Saudi Arabia but remains uncommon in Iraq [43]. In Jordan, a history of blood transfusion, renal transplantation, and similar surgeries were common factors, similar to our study [44]. Similar risk factors, including dental procedures, history of surgery, and blood transfusions, were found to be related to HCV transmission in Turkey [45].

Contrary to the previous studies conducted in Arab countries, Canada, and the United Kingdom, the common mode of HCV acquisition was found to be intravenous drug abuse as a result of sharing needles and other equipment, and there is no significant role of blood transfusion, cupping or other surgery in HCV transmission [46, 47].

Conclusion

This study showed that substance abuse is common among HCV-infected patients (prevalence rate 53.6%). The most commonly abused substance was nicotine, while alcohol and licit drugs were less commonly abused. Smoking and oral use were the most common routes, while intravenous drug abuse was negligible, so there was no relationship between HCV infection and intravenous drug abuse found in this study. The most relevant risk factors for viral transmission were cupping and blood transfusions.

Recommendation

We need further studies with larger sample sizes, and other areas considered to evaluate the extent and effect of substance use among HCV-infected patients. Regular screening of substance abuse among these patients is necessary.

Limitation

The sample included those who sought treatment and attended the Gastrointestinal Tract Centre, while those who still asymptomatic or refuse treatment were not involved.

Availability of data and materials

All data are attached with the supplementary file.

Abbreviations

SUD:

Substance use disorder

UNOC:

United Nation Office on drug and Crime

WHO:

World Health Organization

ATS:

Amphetamine type stimulants

HCV:

Hepatitis C virus

INHSAD:

Iraqi national household survey on alcohol and drug use

IDU:

Injection drug user

HCI:

Housing crowding index

References

  1. Black DW, Grant JE. DSM-5® guidebook: the essential companion to the diagnostic and statistical manual of mental disorders. American Psychiatric Pub. 2014. https://www.appi.org/Products/DSM-Library/DSM-5-Guidebook.

  2. Roberts G. Education sector responses to the use of alcohol, tobacco and drugs. UNESCO Publishing. 2017. https://unesdoc.unesco.org/ark:/48223/pf0000247509.

  3. World Health Organization. WHO report on the global tobacco epidemic, 2017external icon. Geneva: World Health Organization. 2017; 2019. https://www.who.int/publications-detail-redirect/9789241512824.

  4. World Health Organization. Department of mental health, substance. Abuse Global status report on alcohol 2004. Geneva: World Health Organization; 2004.

    Google Scholar 

  5. Naqshbandi MM. Drug addiction and youth of Kashmir. Int NGO J. 2012;7(5):84–90. https://doi.org/10.5897/INGOJ12.022.

    Article  Google Scholar 

  6. Merz F. United nations office on drugs and crime: world drug report 2017. 2017. SIRIUS-Zeitschrift für Strategische Analysen. 2018;2(1):85–6.

    Article  Google Scholar 

  7. Casati A, Sedefov R, Pfeiffer-Gerschel T. Misuse of medicines in the European Union: a systematic review of the literature. Eur Addict Res. 2012;18(5):228–45. https://doi.org/10.1159/000337028.

    Article  PubMed  Google Scholar 

  8. Correa-De-Araujo R, Miller GE, Banthin JS, Trinh Y. Gender differences in drug use and expenditures in a privately insured population of older adults. J Womens Health. 2005;14(1):73–81. https://doi.org/10.1089/jwh.2005.14.73.

    Article  Google Scholar 

  9. Thorell K, Skoog J, Zielinski A, Borgquist L, Halling A. Licit prescription drug use in a Swedish population according to age, gender and socioeconomic status after adjusting for level of multi-morbidity. BMC Public Health. 2012;12:1–7.

    Article  Google Scholar 

  10. Collins D, Abadi MH, Johnson K, Shamblen S, Thompson K. Non-medical use of prescription drugs among youth in an Appalachian population: prevalence, predictors, and implications for prevention. J Drug Educ. 2011;41(3):309–26. https://doi.org/10.2190/DE.41.3.e.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Al-Hemiary N, Talib M. Substance abuse and dependence: in the records of the iraqi hospitals and health centers during the year 2008. Iraqi Postgraduate Med J. 2010; 9(2). https://www.iasj.net/iasj/article/49340.

  12. Aqrawi R, Humphreys K. Responding to rising substance misuse in Iraq. Subst Use Misuse. 2009;44(12):1744–8. https://doi.org/10.3109/10826080902963415.

    Article  PubMed  Google Scholar 

  13. Lafta RK. Health system in Iraq post 2003 war. Al-Kindy Coll Med J. 2023;19(3):5–11. https://doi.org/10.47723/kcmj.v19i3.1040.

    Article  Google Scholar 

  14. Al-Hemiary NJ, Al-Diwan JK, Hasson AL, Rawson RA. Drug and alcohol use in Iraq: findings of the inaugural Iraqi Community epidemiological workgroup. Subst Use Misuse. 2014;49(13):1759–63. https://doi.org/10.3109/10826084.2014.913633.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Al-Hemiery N, Dabbagh R, Hashim MT, Al-Hasnawi S, Abutiheen A, Abdulghani EA, Al-Diwan JK, Kak N, Al Mossawi H, Maxwell JC, Brecht ML. Self-reported substance use in Iraq: findings from the Iraqi National Household Survey of Alcohol and Drug Use, 2014. Addiction. 2017;112(8):1470–9. https://doi.org/10.1111/add.13800.

    Article  PubMed  Google Scholar 

  16. Alhasnawi S, Sadik S, Rasheed MO, Baban A, Al-Alak MM, Othman AY, Othman Y, Ismet N, Shawani O, Murthy S, Aljadiry M. The prevalence and correlates of DSM-IV disorders in the Iraq Mental Health Survey (IMHS). World Psychiatry. 2009;8(2):97. https://doi.org/10.1002/hep.26141.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333–42. https://doi.org/10.1002/hep.26141.

    Article  PubMed  Google Scholar 

  18. Cox AL, Thomas DL. Hepatitis C virus vaccines among people who inject drugs. Clin Infect Dis. 2013;57(2):S46-50. https://doi.org/10.1093/cid/cit329.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Van Asten L, Verhaest I, Lamzira S, Hernandez-Aguado I, Zangerle R, Boufassa F, Rezza G, Broers B, Robertson JR, Brettle RP, McMenamin J. Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis. 2004;189(2):292–302. https://doi.org/10.1086/380821.

    Article  PubMed  Google Scholar 

  20. Tarky AM, Akram WA, Al-Naaimi AS, Omer AR. Epidemiology of viral hepatitis B and C in Iraq: a national survey 2005–2006. Zanco J Med Sci. 2013;17(1):370–80. https://doi.org/10.15218/zjms.2013.0017.

    Article  Google Scholar 

  21. Alzahrani AJ. Analysis of hepatitis C virus core antigenemia in Saudi drug users. 2005;1645–1646.

  22. Diaz T, Des Jarlais DC, Vlahov D, Perlis TE, Edwards V, Friedman SR, Monterroso ER. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan New York City. Am J Public Health. 2001;91(1):23. https://doi.org/10.2105/AJPH.91.1.23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Myles A, Mugford GJ, Zhao J, Krahn M, Wang PP. Physicians’ attitudes and practice toward treating injection drug users infected with hepatitis C virus: results from a national specialist survey in Canada. Canadian J Gastroenterol Hepatol. 2011;25:135–9. https://doi.org/10.1155/2011/810108.

    Article  Google Scholar 

  24. Group WA. The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183–94. https://doi.org/10.1046/j.1360-0443.2002.00185.x.

    Article  Google Scholar 

  25. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). World Health Organization. 2010. https://www.who.int/publications/i/item/978924159938-2. Accessed 1 May 2017.

  26. Hézode C, Zafrani ES, Roudot-Thoraval F, Costentin C, Hessami A, Bouvier-Alias M, Medkour F, Pawlostky JM, Lotersztajn S, Mallat A. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. Gastroenterology. 2008;134(2):432–9. https://doi.org/10.1053/j.gastro.2007.11.039.

    Article  PubMed  Google Scholar 

  27. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996;86(5):655–61. https://doi.org/10.2105/AJPH.86.5.655.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Channon AR, World Health Organization. Iraq Family Health Survey Report IFHS 2006/7. http://www.webcitation.org/6jh4Ppxrj. Accessed 8 Nov 2016.

  29. MOH W. Chronic non-communicable diseases risk factor survey in Iraq: A STEP wise approach. Draft report. 2006.

  30. Butt AA, Evans R, Skanderson M, Shakil AO. Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysis. J Hepatol. 2006;44(5):864–8. https://doi.org/10.1016/j.jhep.2006.01.024.

    Article  PubMed  Google Scholar 

  31. Sharma AK, Upadhyaya SK, Bansal P, Sharma MND. A study of factors affecting relapse in substance abuse. Indian J Life Sci. 2012;2(1):28–33.

    CAS  Google Scholar 

  32. Al-Hemiary NJ, Hashim MT, Al-Diwan JK, Razzaq EA. Alcohol and drug abuse in post-conflict Iraq. J Faculty Med Baghdad. 2015;57(4):290–4.

    Article  Google Scholar 

  33. Fireman M, Indest DW, Blackwell A, Whitehead AJ, Hauser P. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care. Clin Infect Dis. 2005;40(Supplement_5):S286–91. https://doi.org/10.1086/427442.

    Article  PubMed  Google Scholar 

  34. Galdas PM, Cheater F, Marshall P. Men and health help-seeking behaviour: literature review. J Adv Nurs. 2005;49(6):616–23. https://doi.org/10.1111/j.1365-2648.2004.03331.x.

    Article  PubMed  Google Scholar 

  35. Anthony M, Lee KY, Bertram CT, Abarca J, Rehfeld RA, Malone DC, Freeman M, Woosley RL. Gender and age differences in medications dispensed from a national chain drugstore. J Women’s Health. 2008;17(5):735–43. https://doi.org/10.1089/jwh.2007.0731.

    Article  Google Scholar 

  36. Amiri ZM, Rezvani M, Shakib RJ, Shakib AJ. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province. EMHJ-Eastern Mediterranean Health J. 2007;13(2):250–6.

    Google Scholar 

  37. Norouzian H, Gholami M, Shakib P, Goudarzi G, Diali HG, Rezvani A. Prevalence of HCV infections and co-infection with HBV and HIV and associated risk factors among addicts in Drug Treatment Centers, Lorestan Province, Iran. Int J High Risk Behav Addict. 2016. https://doi.org/10.5812/ijhrba.25028.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Daw MA, Dau AA. Hepatitis C virus in Arab world: a state of concern. Sci World J. 2012. https://doi.org/10.1100/2012/719494.

    Article  Google Scholar 

  39. Khattab OS. Prevalence and risk factors for hepatitis C virus infection in hemodialysis patients in an Iraqi renal transplant center. Saudi J Kidney Dis Transplant. 2008;19(1):110–5.

    Google Scholar 

  40. Al Kubaisy WA, Al Naib KT, Habib M. Seroprevalence of hepatitis C virus specific antibodies among Iraqi children with thalassaemia. EMHJ-Eastern Mediterranean Health J. 2006;12(1–2):204–10.

    CAS  Google Scholar 

  41. Souqiyyeh MZ, Al-Attar MB, Zakaria H, Shaheen FA. Dialysis centers in the kingdom of saudi arabia. Saudi J Kidney Dis Transplant. 2001;12(3):293–304.

    CAS  Google Scholar 

  42. Hajiani E, Hashemi J, Masjedizadeh R, Shayesteh AA, Idani E, Rajabi T. Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south-west of Iran: a case-control study. World J Gastroenterol WJG. 2006;12(30):4884. https://doi.org/10.3748/wjg.v12.i30.4884.

    Article  PubMed  Google Scholar 

  43. Madani TA. Hepatitis C virus infections reported over 11 years of surveillance in Saudi Arabia. Trans R Soc Trop Med Hyg. 2009;103(2):132–6. https://doi.org/10.1016/j.trstmh.2008.08.001.

    Article  PubMed  Google Scholar 

  44. Al-Jamal M, Al-Qudah A, Al-Shishi KF, Al-Sarayreh A, Al-Quraan L. Hepatitis C virus (HCV) infection in hemodialysis patients in the south of Jordan. Saudi J Kidney Dis Transplant. 2009;20(3):488–92.

    Google Scholar 

  45. Aykın N, Cevık F, Demırturk N, Demırdal T, Orhan S, Naz H. Anti-HCV positivity in sexual partners and offspring of patient with chronic hepatitis C. Scand J Infect Dis. 2008;40(6–7):533–7. https://doi.org/10.1080/00365540701867313.

    Article  CAS  PubMed  Google Scholar 

  46. Delage G, Infante-Rivard C, Chiavetta JA, Willems B, Pi D, Fast M. Risk factors for acquisition of hepatitis C virus infection in blood donors: results of a case-control study. Gastroenterology. 1999;116(4):893–9. https://doi.org/10.1016/S0016-5085(99)70072-7.

    Article  CAS  PubMed  Google Scholar 

  47. MacLennan S, Moore MC, Hewitt PE, Nicholas S, Barbara JA. A study of anti-hepatitis C positive blood donors: the first year of screening. Transfus Med. 1994;4(2):125–33. https://doi.org/10.1111/j.1365-3148.1994.tb00253.x.

    Article  CAS  PubMed  Google Scholar 

  48. Alibrahim OA, Misau YA, Mohammed A, Faruk MB, Izzeldin SS. Prevalence of hepatitis C viral infection among injecting drug users in a Saudi Arabian hospital: a point cross sectional survey. J Public Health Africa. 2018. https://doi.org/10.4081/jphia.2018.726.

    Article  Google Scholar 

  49. Altawalah H, Essa S, Ezzikouri S, Al-Nakib W. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: a cross-sectional study. Sci Reports. 2019;9(1):6292. https://doi.org/10.1038/s41598-019-42810-w.

    Article  CAS  Google Scholar 

  50. Othman BM, Monem MS. Prostitutes in Damascus, Syria. Saudi Med. J. 2002;23:393–5.

    PubMed  Google Scholar 

Download references

Acknowledgements

I feel greatly privileged to thank Prof. Dr. Nesif Jasim Al-Hemiary, for the opportunity to work with him, and I sincerely appreciate it.

Funding

This research has not received any funding.

Author information

Authors and Affiliations

Authors

Contributions

N. J. A.: selecting the research idea, study design, obtaining ethical approval, and supervision of data collection. N.A. H.: data collection, analysis, interpretation, manuscript writing, and submission. The final manuscript was read and approved by both authors.

Corresponding author

Correspondence to Noor Ali Hasan.

Ethics declarations

Ethical approval and consent to participate

The study was approved by the scientific council of psychiatry of Arab Board for health Specializations (No. 183, February 5th 2017). All patients signed an informed consent form to participate in the study.

Consent for publication

Not applicable.

Competing interests

There is no any competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hasan, N.A., Al-Hemiary, N. Patterns and sociodemographic characteristics of substance abuse among hepatitis C virus-infected patients in Iraq: a cross-sectional study. Egypt J Neurol Psychiatry Neurosurg 60, 94 (2024). https://doi.org/10.1186/s41983-024-00868-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s41983-024-00868-y

Keywords